Back to Top
GEN Protocols

Drug Discovery

Drug Discovery

Application

Batch-to-batch consistency of premium grade bioactive proteins

​​​​This white paper demonstrates the batch-to-batch consistency of our premium grade bioactive proteins (growth factors and cytokines). Designed to meet the exacting demands of cell and gene therapy applications, our premium grade proteins are ideal for controlled cell culture. ​​​​​​​​​​​​​​​​​​​​... More


Application

Technical tips for ELISA and multiplex immunoassay development

Developing a high performance sandwich ELISA or multiplex immunoassay can be complicated, and high performance requires careful development and validation. To help, we have created this guide based on what we have learned during the development of over 500 matched antibody pairs, ELISA kits, and mul... More


Application

Benchling for RNA Therapeutics R&D

Because RNA therapeutics can target conditions that small molecules and proteins cannot address, researchers are now on the verge of treating previously “undruggable” diseases. From the approval of the first antisense oligonucleotide, aptamer, and siRNA, to the now famous launch of mRNA-based COVID-... More


Application

Benchling for Cell Therapy R&D

Cell therapies such as stem cells, CAR T cells, and TCR have been of significant interest in research over the past few decades. The FDA approval of CAR T therapies has led to renewed interest in the field. As companies rush to bring more novel cell therapies to the market, they face several R&D com... More


Application

Benchling for Hybridoma Technology

Hybridoma technology is a well-established method for generating monoclonal antibodies (mAB), but various scientific and organizational challenges persist. Laborious and resource-intensive processes, low titers, and complex assays mean that scientists have to streamline every step, simplify handoffs... More


Premier Sponsor